Wu H, Liu Q, Wang F, Gao W, Zhou F, Zhao H
Onco Targets Ther. 2025; 18():87-106.
PMID: 39845286
PMC: 11752833.
DOI: 10.2147/OTT.S486411.
Li Y, Ding X, Wu X, Ding L, Yang Y, Jiang X
Acta Pharm Sin B. 2023; 13(11):4461-4476.
PMID: 37969726
PMC: 10638517.
DOI: 10.1016/j.apsb.2023.07.028.
Jang J, Kim H, Park S, Kim M, Min Y, Jeong H
Hemasphere. 2023; 7(11):e977.
PMID: 37908861
PMC: 10615405.
DOI: 10.1097/HS9.0000000000000977.
Kuske M, Haist M, Jung T, Grabbe S, Bros M
Cancers (Basel). 2022; 14(7).
PMID: 35406483
PMC: 8996886.
DOI: 10.3390/cancers14071710.
Luczo J, Ronzulli S, Tompkins S
Viruses. 2021; 13(2).
PMID: 33494528
PMC: 7911750.
DOI: 10.3390/v13020156.
Enteroviral Pathogenesis of Type 1 Diabetes: The Role of Natural Killer Cells.
Nekoua M, Dechaumes A, Sane F, Alidjinou E, Moutairou K, Yessoufou A
Microorganisms. 2020; 8(7).
PMID: 32630332
PMC: 7409131.
DOI: 10.3390/microorganisms8070989.
Transcriptome analysis reveals similarities between human blood CD3 CD56 cells and mouse CD127 innate lymphoid cells.
Allan D, Cerdeira A, Ranjan A, Kirkham C, Aguilar O, Tanaka M
Sci Rep. 2017; 7(1):3501.
PMID: 28615725
PMC: 5471261.
DOI: 10.1038/s41598-017-03256-0.
Characterization of a human anti-tumoral NK cell population expanded after BCG treatment of leukocytes.
Garcia-Cuesta E, Esteso G, Ashiru O, Lopez-Cobo S, Alvarez-Maestro M, Linares A
Oncoimmunology. 2017; 6(4):e1293212.
PMID: 28507799
PMC: 5414876.
DOI: 10.1080/2162402X.2017.1293212.
Current perspectives on natural killer cell education and tolerance: emerging roles for inhibitory receptors.
Thomas L
Immunotargets Ther. 2016; 4:45-53.
PMID: 27471711
PMC: 4918248.
DOI: 10.2147/ITT.S61498.
CD300c is uniquely expressed on CD56 bright Natural Killer Cells and differs from CD300a upon ligand recognition.
Dimitrova M, Zenarruzabeitia O, Borrego F, Simhadri V
Sci Rep. 2016; 6:23942.
PMID: 27040328
PMC: 4819222.
DOI: 10.1038/srep23942.
CD56(dim)CD16(high) and CD56(bright)CD16(-) cell percentages associated with maximum knee extensor strength and incidence of death in elderly.
Senpuku H, Miyazaki H, Yoshihara A, Yoneda S, Narisawa N, Kawarai T
Springerplus. 2016; 5:244.
PMID: 27027597
PMC: 4771652.
DOI: 10.1186/s40064-016-1884-3.
Chemokine Receptor Expression on Normal Blood CD56(+) NK-Cells Elucidates Cell Partners That Comigrate during the Innate and Adaptive Immune Responses and Identifies a Transitional NK-Cell Population.
Lima M, Leander M, Santos M, Santos A, Lau C, Queiros M
J Immunol Res. 2015; 2015:839684.
PMID: 26543875
PMC: 4620293.
DOI: 10.1155/2015/839684.
IL-27 imparts immunoregulatory function to human NK cell subsets.
Laroni A, Gandhi R, Beynon V, Weiner H
PLoS One. 2011; 6(10):e26173.
PMID: 22039443
PMC: 3198386.
DOI: 10.1371/journal.pone.0026173.
Tissue-specific homing and expansion of donor NK cells in allogeneic bone marrow transplantation.
Olson J, Zeiser R, Beilhack A, Goldman J, Negrin R
J Immunol. 2009; 183(5):3219-28.
PMID: 19657090
PMC: 2880476.
DOI: 10.4049/jimmunol.0804268.
CD56bright natural killer (NK) cells: an important NK cell subset.
Poli A, Michel T, Theresine M, Andres E, Hentges F, Zimmer J
Immunology. 2009; 126(4):458-65.
PMID: 19278419
PMC: 2673358.
DOI: 10.1111/j.1365-2567.2008.03027.x.
Natural killer cells require selectins for suppression of subcutaneous tumors.
Sobolev O, Stern P, Lacy-Hulbert A, Hynes R
Cancer Res. 2009; 69(6):2531-9.
PMID: 19258505
PMC: 2694740.
DOI: 10.1158/0008-5472.CAN-08-3126.
The trafficking of natural killer cells.
Gregoire C, Chasson L, Luci C, Tomasello E, Geissmann F, Vivier E
Immunol Rev. 2007; 220:169-82.
PMID: 17979846
PMC: 7165697.
DOI: 10.1111/j.1600-065X.2007.00563.x.
Phenotypic studies of natural killer cell subsets in human transporter associated with antigen processing deficiency.
Zimmer J, Bausinger H, Andres E, Donato L, Hanau D, Hentges F
PLoS One. 2007; 2(10):e1033.
PMID: 17940597
PMC: 2001180.
DOI: 10.1371/journal.pone.0001033.
Suppression of tumor formation in lymph nodes by L-selectin-mediated natural killer cell recruitment.
Chen S, Kawashima H, Lowe J, Lanier L, Fukuda M
J Exp Med. 2005; 202(12):1679-89.
PMID: 16352740
PMC: 2212958.
DOI: 10.1084/jem.20051473.
Increased primary tumor growth in mice null for beta3- or beta3/beta5-integrins or selectins.
Taverna D, Moher H, Crowley D, Borsig L, Varki A, Hynes R
Proc Natl Acad Sci U S A. 2004; 101(3):763-8.
PMID: 14718670
PMC: 321755.
DOI: 10.1073/pnas.0307289101.